Even if it is not clear yet where the process begins, visceral adiposity certainly plays a key role in initiating IR and subsequent liver injury, even in the absence of increased BMI or an overt diagnosis of diabetes or metabolic syndrome, also conferring an increased risk of NAFLD, especially in PNPLA3 carriers [20,121]. Here, PNPLA3 is linked to diabetes mellitus.